Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Aclaris Therapeutics (0H8T.LSE) Q2 2024 Earnings
0H8T.LSE
7
May
Confirmed
Q2 2024
-0.29
-0.27
-0.26
-0.24
Details
Expected EPS
-0.285714
Actual EPS
-0.24
Surprise EPS
0.05
Surprise Percent
+16%
Description
Aclaris Therapeutics (0H8T.LSE) has reported earnings of -0.24 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login